ADENTRA (TSE:ADEN – Get Free Report) had its price objective dropped by equities researchers at Scotiabank from C$49.00 to C$43.00 in a report issued on Monday,BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock.
ADEN has been the subject of several other reports. National Bankshares decreased their price objective on shares of ADENTRA from C$60.00 to C$53.00 and set an “outperform” rating for the company in a report on Monday. CIBC decreased their price objective on shares of ADENTRA from C$49.00 to C$44.00 and set an “outperform” rating for the company in a report on Monday. Raymond James set a C$60.00 price objective on shares of ADENTRA and gave the stock a “strong-buy” rating in a report on Friday, December 20th. Finally, Cormark decreased their price target on shares of ADENTRA from C$55.00 to C$46.00 in a report on Monday. Six research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $48.13.
Get Our Latest Research Report on ADEN
ADENTRA Price Performance
ADENTRA Company Profile
ADENTRA Inc engages in the wholesale distribution of architectural building products to the residential, repair and remodel, and commercial construction markets in Canada and the United States. It offers doors, decorative surfaces, moldings, stair parts, hardwood lumber, hardwood plywood, composite panels, and other building products to industrial manufacturers, home builder distribution yards, and home centers.
See Also
- Five stocks we like better than ADENTRA
- Financial Services Stocks Investing
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How to Invest in the FAANG Stocks
- 3 Must-Own Stocks to Build Wealth This Decade
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.